Abacavir/Lamivudine/Zidovudine

Abacavir/lamivudine/zidovudine is a medication that is licensed for the treatment of HIV and AIDS. It is made up of three different HIV medicines and works by preventing the HIV virus from infecting uninfected cells in the body. Abacavir/lamivudine/zidovudine is available by prescription and comes in a tablet form that is generally taken twice daily. Potential side effects of the medication include headache, nausea, and fatigue.

 

What Is Abacavir/Lamivudine/Zidovudine?

Abacavir/lamivudine/zidovudine (Trizivir®) is a prescription medication used to treat HIV infection or AIDS. It is approved for use alone or in combination with other HIV medications as a treatment for HIV. Abacavir/lamivudine/zidovudine contains three different medications, abacavir (Ziagen®, ABC), lamivudine (Epivir®, 3TC), and zidovudine (Retrovir®, AZT, ZDV).
 
(Click What Is Abacavir/Lamivudine/Zidovudine Used For? for more information on abacavir/lamivudine/zidovudine uses, including possible off-label uses.)
 

Abacavir/Lamivudine/Zidovudine Side Effects

As with any medicine, side effects are possible with abacavir/lamivudine/zidovudine. However, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious side effects are less common.
 
Common side effects of abacavir/lamivudine/zidovudine include, but are not limited to:
 
  • Nausea
  • Headaches
  • Fatigue or a general ill feeling (malaise)
  • Vomiting (with nausea).
     
(Click Side Effects of Abacavir/Lamivudine/Zidovudine to learn more, including potentially serious side effects that you should report immediately to your healthcare provider.)
 
(Abacavir/Lamivudine/Zidovudine Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;